Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Looking good at open

<< Previous

Bullboard Posts

Next >>

Comment by Bullchart1on Mar 01, 2021 9:26am

162 Views

Post# 32684220

RE:RE:Looking good at open

That is what happens... No trading for months... consoladate.... then some just want their money back..

Keep an eye on the Nov 2017 move. This can do the unexpected.

Moonshiner592 wrote:

Chritters wrote: Level 2 is looking good at open, May open at 9-10 cents. Anyone even thinking of flipping right now you deserve what you get to flip this now.

I wouldn't - more news on the way!! I would not want to miss the boat here!!